Literature DB >> 35898239

Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?

Francesco Ferrara1, Carolina Mancaniello1, Livia Nava2, Alessandra Salierno1, Raffaele Casillo1, Ugo Trama3, Eduardo Nava1, Antonio Vitiello4.   

Abstract

Entities:  

Year:  2022        PMID： 35898239      PMCID： PMC9310303          DOI： 10.1177/00185787211069040

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  4 in total

1.  Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.

Authors:  Jean-Louis Montastruc; Agnès Sommet; Haleh Bagheri; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 2.  [Case-non case studies: Principles, methods, bias and interpretation].

Authors:  Jean-Luc Faillie
Journal:  Therapie       Date:  2017-10-31       Impact factor: 2.070

3.  COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view.

Authors:  Antonio Vitiello; Raffaele La Porta; Laura Pianesi; Francesco Ferrara
Journal:  Ir J Med Sci       Date:  2021-03-12       Impact factor: 1.568

Review 4.  The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.

Authors:  Shibi Muralidar; Senthil Visaga Ambi; Saravanan Sekaran; Uma Maheswari Krishnan
Journal:  Biochimie       Date:  2020-09-22       Impact factor: 4.079
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.